Company profile
constructive.bio
Constructive Biology Limited is a UK company with status active founded in 2021 based in London.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUxNjYyNDc1MGFkaXF6a2N4
Published 16 Apr 2026 08:44
Last accounts made up date
Last confirmation statement made up date
CS01 | Transaction MzQ0NDQ2NTM2OWFkaXF6a2N4
Published 21 Nov 2024 05:27
AA01 | Transaction MzQ0MTg2NTEwNmFkaXF6a2N4
Published 04 Nov 2024 10:00
RESOLUTIONS | Transaction QUREMTNaR1FhZGlxemtjeA | Paper/PDF filed
Published 13 Oct 2024 06:07
SH01 | Transaction MzQzODQxNDY3MWFkaXF6a2N4
Published 04 Oct 2024 10:06
MA | Transaction MzQzNzAzNDA2OGFkaXF6a2N4 | Paper/PDF filed
Published 30 Sep 2024 05:43
RESOLUTIONS | Transaction WURDQjVOMlphZGlxemtjeA | Paper/PDF filed
Published 30 Sep 2024 05:41
PSC08 | Transaction MzQzNzE2NzAyN2FkaXF6a2N4
Published 25 Sep 2024 09:45
PSC07 | Transaction MzQzNzE2MjUxMWFkaXF6a2N4
Published 25 Sep 2024 09:15
PSC07 | Transaction MzQzNzE2MjEzMGFkaXF6a2N4
Published 25 Sep 2024 09:13
TM01 | Transaction MzQzNzE1ODIwNWFkaXF6a2N4
Published 25 Sep 2024 08:51
TM01 | Transaction MzQzNzE1Nzc0NWFkaXF6a2N4
Published 25 Sep 2024 08:48
TM01 | Transaction MzQzNzE1NzY4NmFkaXF6a2N4
Published 25 Sep 2024 08:48
AP01 | Transaction MzQzNzE1MDExMGFkaXF6a2N4
Published 25 Sep 2024 08:05
AP01 | Transaction MzQzNzE1MDEwOGFkaXF6a2N4
Published 25 Sep 2024 08:05
Company registered at Companies House
1 Feb 2026 to 31 Jul 2026
The world is experiencing a sharp rise in the use of therapeutic peptides---particularly the new GLP-1 medicines for obesity and diabetes. Demand is increasing so rapidly that global production is projected to reach metric-tonne levels in the coming years. Currently, almost all these medicines are produced through a chemical process called solid-phase pep...
1 Feb 2026 to 30 Jun 2026
Therapeutic peptides, such as GLP-1 agonists, are becoming one of the fastest-growing classes of modern medicines, with future demand expected to reach metric-tonne scale. Yet most peptides are still produced by solid-phase peptide synthesis (SPPS), a resource-intensive process that uses large quantities of solvents and can generate over 10,000 kg of wast...
1 Feb 2025 to 31 Jan 2027
Therapeutic peptides are set to dominate the top-selling drugs list over the next decade. Incretin mimetics such as Semaglutide (brand names Ozempic/Wegovy/Rybelsus) and Tirzepatide (brand names Zepbound/Mounjaro) are projected to make up 5 of the top 10 selling drugs by 2030, with combined sales of $116Bn. Each of these active pharmaceutical ingredients ...
